Obesity can be deadly for people living with it, but we have potential treatments that can lead to weight loss and ...

In addition, the decline in overall obesity rate reported by the CDC isn’t the first such drop. Between 1999 and 2018, the ...

The researchers emphasized ... Nov. 26, 2024 — Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three ...

The latest in health news includes Zealand Pharma's obesity drug trial, a record dengue outbreak in the Americas, CervoMed's ...

Most people who lose weight through dieting will see it creep back up, leading to a cycle of "yo-yo dieting" that's hard on ...

Oh dear, Keir. In late October, I issued a 100-day appeal for the gloomsters and doomsters to pipe down and just let the new ...

BioAge Labs’ stock lost more than two-thirds of its market cap in pre-market trading Monday, poised to hit an all-time low ...

The map shows states that Kennedy may target first as part of his initiative, due to the high levels of obesity prevalence in ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

After a lucrative IPO in September, Richmond-based BioAge is seeing its biotech fortunes shift with its stock falling over 70 ...

Eli Lilly and Co. will begin studies to see if its blockbuster weight-loss medicines are also effective at controlling addictive behaviors like alcohol abuse, smoking and drug addiction, Chief ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers told us how they cope. Medscape Medical News, November 14, 2024 Obesity ...